SLI
ALNY icon

Sumitomo Life Insurance’s Alnylam Pharmaceuticals ALNY Stock Holding History

Sumitomo Life Insurance’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Buy
3,284
+90
+3% +$30.6K 0.03% 180
2025
Q4 		$1.27M Buy
3,194
+27
+0.9% +$11.9K 0.03% 166
2025
Q3 		$1.44M Buy
3,167
+1,049
+50% +$427K 0.04% 150
2025
Q2 		$691K Buy
+2,118
New +$586K 0.05% 210

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Life Insurance's ALNY Position: Q1 2026 in Review

Sumitomo Life Insurance increased its Alnylam Pharmaceuticals (ALNY) stake by 2.8% in Q1 2026, buying an estimated $30.6K and bringing the position to 3,284 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #180.

Sumitomo Life Insurance first reported a position in ALNY in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.44M in Q3 2025. 787 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Sumitomo Life Insurance held 3,284 shares of Alnylam Pharmaceuticals worth $1.09M as of Q1 2026.
  • Sumitomo Life Insurance bought 90 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $30.6K.
  • Alnylam Pharmaceuticals made up 0.03% of Sumitomo Life Insurance's portfolio in Q1 2026, its #180 holding.
  • Sumitomo Life Insurance first reported a position in Alnylam Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • Sumitomo Life Insurance's Alnylam Pharmaceuticals position peaked at $1.44M in Q3 2025.
  • 787 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Sumitomo Life Insurance's 13F filing for Q1 2026, filed 12 May 2026.